neoplasm
• starting at week 20, mice develop spontaneous tumors as they age including melanomas, hepatocellular carcinomas, spontaneous lung adenocarcinomas, angiosarcomas, mammary carcinomas, lymphomas, sarcomas, and lung and soft tissue tumors
• by 2 years of age, the incidence of spontaneous tumor reaches about 12% compared to 1 to 2% in wild-type and heterozygous mice
|
• mice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotypemice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotype
|
• mice exhibit multifocal, large and rapidly growing lung tumors in response to urethane unlike similarly treated wild-type mice that do not develop lung tumors
|
respiratory system
• mice exhibit multifocal, large and rapidly growing lung tumors in response to urethane unlike similarly treated wild-type mice that do not develop lung tumors
|
endocrine/exocrine glands
• mice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotypemice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotype
|
hematopoietic system
• mice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotypemice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotype
|
immune system
• mice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotypemice treated with a dose of gamma radiation that induces a very low incidence of thymic lymphomas exhibit a 30% incidence with a CD4-CD8-TCRalphabetalow phenotype
|